Wall Street Is Wrong About Oracle — This $553 Billion Backlog Tells a Different Story for 2026

Wall Street Is Wrong About Oracle — This 3 Billion Backlog Tells a Different Story for 2026


Key Points

Wall Street is clearly flashing warning signs about technology giant Oracle (NYSE: ORCL). The stock has lost more than half of its value in just six months. And yet, the company’s fiscal third quarter 2026 earnings highlighted a massive backlog of $553 billion. Here’s why more aggressive investors may want to stay positive about Oracle’s future.

Oracle has a lot of work to do

Oracle is helping to build out the infrastructure needed to support artificial intelligence (AI). Much of the $553 billion backlog (which the company calls remaining performance obligations) relates to the construction of data centers that house AI computers. These aren’t optional assets; AI has to live somewhere.

Will AI create the world’s first trillionaire? Our team just released a report on the one little-known company, called an “Indispensable Monopoly” providing the critical technology Nvidia and Intel both need. Continue »

Two people looking at a giant screen with graphs on it.

Image source: Getty Images.

Oracle has positioned itself as a vital “picks-and-shovels” provider to the companies that want to use AI. In fact, the company’s backlog was up 325% year over year, showing the immense demand for AI infrastructure. Demand for AI infrastructure is so strong that management expects “to comfortably meet and likely exceed our revenue growth rate forecast for FY27 and beyond.”

Wall Street’s deeply negative view of Oracle stock doesn’t line up with that outlook, noting that the company’s adjusted earnings rose 21% year over year in the fiscal third quarter.

There are risks to consider with Oracle

If everything works out as well as Oracle hopes, it is highly likely that Wall Street’s negative view of the stock is dead wrong. And the massive $553 billion backlog hints at this. If you are an aggressive investor, it might be worth digging into Oracle’s growth story.

The problem with this technology company’s story lies in its balance sheet. That’s where you will notice that Oracle’s debt load has increased dramatically, with long-term debt rising by nearly 50% in less than a year. Management is very clear that building data centers requires huge upfront costs. That said, the company also appears aware of the issue, because it is adjusting its approach to include more pre-funding from customers. If customers start canceling orders for any reason, however, Oracle’s material levels of debt could become a worrying headwind.

In the end, Oracle is clearly making a sizable bet on AI infrastructure. Only more aggressive investors should buy the stock. However, if you believe that AI is a technology that will change the world, the sell-off in Oracle’s stock could be your entry point into a well-respected AI “picks-and-shovels” play in 2026.

Should you buy stock in Oracle right now?

Before you buy stock in Oracle, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Oracle wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $532,066!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,087,496!*

Now, it’s worth noting Stock Advisor’s total average return is 926% — a market-crushing outperformance compared to 185% for the S&P 500. Don’t miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of April 5, 2026.

Reuben Gregg Brewer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Oracle. The Motley Fool has a disclosure policy.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



Source link


Discover more from stock updates now

Subscribe to get the latest posts sent to your email.

Leave a Reply

SleepLean – Improve Sleep & Support Healthy Weight